Cerapedics Stock
CeraPedics is a medical device company that focuses on developing and commercializing novel osteobiologic products.
Sign up today and learn more about Cerapedics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cerapedics Stock
Cerapedics is an orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. The company was founded in 2001 and is headquartered in Westminster, Colorado.
Funding History
| February 2007 | $12.3M |
|---|---|
| October 2007 | $16.4M |
| April 2009 | $15.0M |
| February 2012 | $3.0M |
| July 2012 | $19.0M |
| April 2014 | $9.0M |
| February 2015 | $4.0M |
| April 2015 | $4.0M |
| September 2016 | $11.0M |
| April 2017 | $20.0M |
| July 2018 | $22.0M |
| January 2019 | $45.0M |
| March 2022 | $25.0M |
Management
Founder
Andrew Tofe
Board of Directors
Chau Khuong
President & COO
Jeffrey G. Marx
CEO
Glen A. Kashuba
Chairman of the Board of Directors
Jonathan Silverstein
Press
bizwest - Jul, 28 2023
Cerapedics grows HQ to accommodate more manufacturing, R&Dmedicaldesignandoutsourcing - May, 4 2021
Cerapedics’ bone graft gains FDA breakthrough nodsocaltech - Feb, 19 2021
Performio Sees Growth After HQ Move To Irvineprnewswire - Jul, 9 2019
Cerapedics Announces Expansion of Colorado Headquarterstechrockies - Jul, 17 2018
Rocky Mountain Tech Map – Put Your Company On The Map!techrockies - Jul, 17 2018
Cerapedics Scores $22M For Bone Graftsfinsmes - Jul, 16 2018
Orthobiologics Company Cerapedics Closes $22M Financingprnewswire - Jul, 14 2018
Cerapedics Announces Closing of $22 Million Financingprnewswire - Jun, 14 2018
Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solutionprnewswire - May, 21 2018
Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR™ Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surgerymassdevice - Mar, 15 2018
Cerapedics wins FDA IDE nod for P-15L bone graft trialprnewswire - Mar, 15 2018
Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgeryprnewswire - Feb, 6 2016
Cerapedics Announces Publication of Results from Pivotal IDE Clinical Trial of i-FACTOR™ Bone Graft in the Cervical Spineprnewswire - Nov, 4 2015
Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgeryfinsmes - Sep, 29 2015
Cerapedics Raises $8Mmassdevice - Sep, 29 2015
ForSight Vision5 pulls down a $15 million Series C round | Medtech funding stories for the week of Apr. 21, 2014finsmes - Sep, 29 2015
Cerapedics Closes $9M Venture Debt Financing from GE CapitalEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
